REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,395,855 | -1.2% | 23,498 | -11.9% | 0.00% | 0.0% |
| Q1 2023 | $2,424,201 | +165.1% | 26,663 | +10.8% | 0.00% | – |
| Q4 2022 | $914,420 | +44.2% | 24,070 | -4.5% | 0.00% | – |
| Q3 2022 | $634,000 | -9.8% | 25,204 | +8.9% | 0.00% | – |
| Q2 2022 | $703,000 | -3.7% | 23,142 | +3.9% | 0.00% | – |
| Q1 2022 | $730,000 | +24.1% | 22,282 | -0.1% | 0.00% | – |
| Q4 2021 | $588,000 | -73.7% | 22,300 | +0.2% | 0.00% | -100.0% |
| Q3 2021 | $2,238,000 | -7.4% | 22,253 | +30.4% | 0.00% | 0.0% |
| Q2 2021 | $2,416,000 | +45.4% | 17,067 | +2.4% | 0.00% | 0.0% |
| Q1 2021 | $1,662,000 | -16.1% | 16,665 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $1,980,000 | +7.4% | 16,021 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $1,843,000 | -37.8% | 18,916 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $2,963,000 | +46.1% | 18,991 | +35.1% | 0.00% | 0.0% |
| Q1 2020 | $2,028,000 | -25.2% | 14,054 | +6.0% | 0.00% | 0.0% |
| Q4 2019 | $2,711,000 | +234.3% | 13,259 | +31.2% | 0.00% | – |
| Q3 2019 | $811,000 | +115.7% | 10,107 | +154.0% | 0.00% | – |
| Q2 2019 | $376,000 | +19.4% | 3,979 | +7.8% | 0.00% | – |
| Q1 2019 | $315,000 | +64.1% | 3,691 | +8.1% | 0.00% | – |
| Q4 2018 | $192,000 | -23.2% | 3,414 | +11.5% | 0.00% | – |
| Q3 2018 | $250,000 | +190.7% | 3,062 | +24.2% | 0.00% | – |
| Q2 2018 | $86,000 | +115.0% | 2,465 | +25.3% | 0.00% | – |
| Q1 2018 | $40,000 | -53.5% | 1,968 | -36.0% | 0.00% | – |
| Q4 2017 | $86,000 | -19.6% | 3,075 | -10.3% | 0.00% | – |
| Q3 2017 | $107,000 | +37.2% | 3,429 | +39.2% | 0.00% | – |
| Q2 2017 | $78,000 | +254.5% | 2,464 | +155.9% | 0.00% | – |
| Q1 2017 | $22,000 | +69.2% | 963 | +56.3% | 0.00% | – |
| Q4 2016 | $13,000 | – | 616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |